• eleonora.nicolai@unicamillus.org

Eleonora Nicolai

Biochemistry - BIO/10
Applied Physics - FIS/07


Graduated in Physics in 2001 from the University of Rome Tor Vergata. In 2006, she obtained her Ph.D. in “Biochemistry and Molecular Biology” from the University of Rome Tor Vergata. She was a visiting doctoral student at the Laboratory of Dynamic Fluorescence, LFD at the University of Urbana Champaign (IL, USA). Since 2008, she has been employed with an indefinite contract as a Scientific Technician and Data Processing Expert at the University of Rome Tor Vergata.

In 2016, she earned a second-level university Master’s degree in “Radiation Protection: Safety in the field of ionising and non-ionising radiation”. Her research activity aims to solve laboratory medicine problems through physical means. It spans various areas of medical application and is carried out in collaboration with important national and international research centres and universities, as well as private companies for technology transfer from academia to industry.

In recent years, her focus has been on the development and clinical validation of new instrumentation and measurement protocols for rapid diagnosis in clinical biochemistry, including: optimisation and validation of a “fast screening” system for bacteriuria in urine using fluorescence probes; development and clinical validation of a protocol for rapid antibiotic susceptibility testing; optimisation of biocompatible surfaces for purposes related to dental practice.

Currently she is involved in the following research projects:

  • Study of the antibody response induced by Covid-19 vaccines and comparison of new tests available on the market for the detection of TORCH antibodies (toxoplasma, rubella, cytomegalovirus, herpes simplex) in collaboration with the Department of Biomedical Sciences, Faculty of Health Sciences, Qatar University, Doha, Qatar;
  • Retrospective study on the influence of diabetes on the prognosis of Sars-CoV2 infected patients in collaboration with the Department of Biomedical Sciences of the University of Sassari;
  • Evaluation of the effectiveness of a new platelet counting technology capable of preventing interferences, in collaboration with Mindray Biomedical Electronics Co., Shenzen, China.
  • Validation of Point-of-Care Testing (POCT) for clinical biochemistry tests in collaboration with Zhejiang Pushkang Biotechnology Co., Ltd., Shaoxing City, China.
  • Development of a prototype for the quantitative detection of microplastics in water in collaboration with the Department of Industrial Engineering, University of Rome Tor Vergata and the company Resind srl (RM, Italy).


Author of 54 publications in international journals.

Academic Editor for the journal “PlosOne”. Guest Editor of the journal “Antibiotics”. Reviewer of numerous international journals.